PI3K inhibitor BGT226
Term · Oncology and biomedicine · MLC-T-ONC-016027
A phosphatidylinositol 3-kinase (PI3K) inhibitor with potential antineoplastic activity. PI3K inhibitor BGT226 specifically inhibits PIK3 in the PI3K/AKT kinase (or protein kinase B) signaling pathway, which may trigger the translocation of cytosolic Bax to the mitochondrial outer membrane, increasing mitochondrial membrane permeability; apoptotic cell death may ensue. Bax is a member of the proapoptotic Bcl2 family of proteins.
| Identifier | MLC-T-ONC-016027 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | phospatidylinositol 3'-kinase inhibitor BGT226 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-016027",
"term": "PI3K inhibitor BGT226",
"field": "Oncology and biomedicine",
"definition": "A phosphatidylinositol 3-kinase (PI3K) inhibitor with potential antineoplastic activity. PI3K inhibitor BGT226 specifically inhibits PIK3 in the PI3K/AKT kinase (or protein kinase B) signaling pathway, which may trigger the translocation of cytosolic Bax to the mitochondrial outer membrane, increasing mitochondrial membrane permeability; apoptotic cell death may ensue. Bax is a member of the proapoptotic Bcl2 family of proteins.",
"synonyms": [
"phospatidylinositol 3'-kinase inhibitor BGT226"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/pi3k-inhibitor-bgt226/"
}
Record 13,191 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.